Table 2.

Targets of ZLJSD in noninvasive and invasive bladder urothelial carcinoma.

Names	Total	Elements
Invasive BLCA & noninvasive BLCA	39	PTGER3, MMP2, CDK1, FOS, PRKCB, NR3C2, RXRA, PPARG, PTGS1, F3, CHEK2, BCL2, CCL2, PRKCA, SLC2A4, IL-6, PTGS2, BIRC5, PPP3CA, TP63, CCNB1, ADRA2A, CYP1B1, CXCL2, F7, ADH1C, KCNH2, CHRM3, ADRA1D, CAV1, JUN, PGR, CHRM2, RUNX1T1, CCNA2, CASP8, ERBB3, CALM1, and MAOB
Noninvasive BLCA	30	CYP1A2, PPARD, NFKBIA, IGFBP3, CHUK, COL3A1, IGF2, RELA, VCAM1, COL1A1, CYP3A4, TNFSF15, SCN5A, PLAT, SLPI, NCF1, SLC6A4, IKBKB, DPP4, HAS2, MMP3, IL-1B, ICAM1, SELE, IRF1, SOD1, ODC1, PCOLCE, ADRA1B, and GJA1
Invasive BLCA	16	IL-4, CHEK1, ACACA, EIF6, MMP1, STAT1, PSMD3, ADRB2, VEGFA, TOP2A, CDK2, AHR, CASP3, E2F1, E2F2, and ERBB2